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Functional Disability and Nursing Resource Use Are Predictive
of Antimicrobial Resistance in Nursing Homes
Lillian Min, MD, MSHS,*† Andrzej Galecki, MD, PhD,*‡ and Lona Mody, MD, MSc*†
OBJECTIVES: To use a simple measure of activities of
daily living, wounds, and indwelling devices (urinary cath-
eter, feeding tube) to predict prevalent, new, and intermit-
tent multidrug-resistant organism (MDRO) acquisition in
nursing home (NH) residents.
DESIGN: Secondary analysis, prospective cohort study.
SETTING: Southeast Michigan NHs (n = 15).
PARTICIPANTS: NH residents (N = 111, mean age 81)
with two or more monthly visits (729 total).
MEASUREMENTS: Monthly microbiological surveillance
for MDROs from multiple anatomic sites from enrollment
until discharge or 1 year. The Arling scale, previously
developed as a measure of NH residents’ need (time-inten-
sity) for nursing resources, was used to predict prevalent
and time to new or intermittent acquisition (months) of
methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant enterococci (VRE), and antibiotic-
resistant gram-negative bacteria (R-GNB) colonization
using multiple-failure accelerated time-factor survival
analysis, controlling for comorbidity, hospitalization, and
antibiotic use in the prior month.
RESULTS: One-fifth of participants had a wound, and
one-third had a device. There were 60 acquisitions of
MRSA, 56 of R-GNB, and 15 of VRE. Expected time to
acquisition was less than 1 year for MRSA (median
6.7 months) and R-GNB (median 4.5 months) and more
than 1 year for VRE (median 40 months). Arling score
was associated with earlier new MRSA and VRE acquisi-
tion. A resident with only mild functional impairment and
no device or wound would be expected to acquire MRSA
in 20 months, versus 5 months for someone needing the
most-intense nursing contact.
CONCLUSION: MDRO acquisition is common in com-
munity NHs. Need for nursing care predicts new MDRO
acquisition in NHs, suggesting potential mechanisms for
MDRO acquisition and strategies for future interventions
for high-risk individuals (e.g., enhanced barrier precau-
tions). J Am Geriatr Soc 63:659–666, 2015.
Key words: functional disability; multidrug-resistant
organisms; nursing homes
Multidrug-resistant organisms (MDROs) are endemicin nursing homes (NHs), with prevalence rates sur-
passing those in hospitals.1–4 Indwelling device use, prior
antibiotic exposure, presence of a wound or pressure ulcer,
and prior hospitalization are considered to be individual
risk factors for colonization with MDROs.5 Retrospective
and cross-sectional studies have shown that older adults
with greater functional disability are at greater risk of
symptomatic infection6,7 and asymptomatic colonization
with MDROs whether they reside in NHs or have been
transferred from a NH to acute care.8–10 In a cross-sec-
tional study, active surveillance for MDROs showed a
dose–response relationship between a NH resident’s over-
all functional disability burden and MDRO colonization.8
Subsequently, a prospective study identified functional dis-
ability as an independent risk factor for NH residents to
acquire new MDROs over 1 year of care.9,11
It was hypothesized that functional disability was
related to MDRO acquisition because of greater need for
contact with healthcare professionals. How many months,
on average, it took for NH residents to become newly col-
onized with MDRO at each level of intensity of nursing
care (defined according to functional impairment and need
for other skilled nursing assistance) was measured.
METHODS
Data were analyzed from a prior prospective microbial
study involving 15 community-based NHs in southeast
Michigan. Details of the study design have been
reported.12 Briefly, this prospective observational study
was conducted from October 2005 to January 2010.
Participating NH facilities accepted people from local
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hospitals, but none were academic or hospital-based NHs.
Bed size ranged from 71 to 161. Four sites were nonprofit
or operated by the county government, and the remaining
11 were for-profit facilities. All residents with an indwell-
ing device (urinary catheter or enteral feeding tube) were
approached for recruitment. Upon enrollment of a resident
with an indwelling device, a device-free resident was ran-
domly approached for recruitment as a control. All partici-
pating residents were followed for a maximum of
12 months or until loss to follow-up, which occurred due
to death, refusal to continue with monthly cultures, or
device removal. The University of Michigan and Veterans
Affairs Ann Arbor Health Care System institutional review
boards approved this study. Written informed consent for
enrollment was obtained from all participants or appropri-
ate proxies.
Demographic data were recorded at enrollment, and
clinical and microbiologic data were obtained at baseline
and every month thereafter until death or discharge. Sam-
ples were collected monthly from the nares, oropharynx,
groin, perianal area, and any wounds or device sites.13
Standard microbiological methods were used to identify
methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant enterococcus (VRE), and antibiotic-
resistant gram-negative bacteria (R-GNB, to ciprofloxacin
or ceftazidime) organisms. To test the hypothesis that
higher nursing resource use would lead to shorter time to
acquisition of MDROs, only residents with at least a base-
line and one follow-up culture were included in the study.
Trained research personnel obtained participant data
such as age at time of enrollment, sex, functional status,
presence of indwelling device (urinary catheter or enteral
feeding tube), and comorbid illnesses from medical
records. Baseline function was assessed for severity of
impairment in six activities of daily living (ADLs: bathing,
toileting, dressing, feeding, walking, grooming) using the
Lawton-Brody Physical Self-Maintenance Scale (PSMS,
range 1–5,14 1 = independent with the ADL, 2 = needs
reminders, 3 = needs moderate assistance, 4 = needs exten-
sive assistance, 5 = needs full assistance or resistant to
care). Comorbidity was calculated using the Charlson
Comorbidity Index (CCI).15 Data were also collected on
time-varying variables such as hospitalization, antibiotic
use, and presence of wounds or pressure ulcers in the prior
30 days.
Research by Arling and associates16 was adapted to
estimate each participant’s need for nursing care, based on
ADL impairment severity, device presence, and wounds. It
was decided to use the Arling criteria because of their sim-
plicity, reducing the variables that Medicare uses to deter-
mine NH case-mix17 to a simpler set of variables that
were subsequently validated in a time-motion study of
nursing intensity of care.16 The scale has excellent fit with
relative observed nursing usage time (53% of variance).16
The method classifies patients into six groups, using feed-
ing dependence, overall ADL impairment, devices, and
wounds to determine the groups. Each group is associated
with a weight representing the ratio between average nurs-
ing time spent on care for that group and that spent on a
normative group of residents in the same NH.
To convert the PSMS-based ADL impairments, disabil-
ity of 4 or 5 (extensive or greater assistance) was
converted to 2 ADL points in the Arling method, and dis-
ability of 2 or 3 (some assistance) was converted to 1 ADL
point. An individual’s ADL score using the Arling method
is the sum of all ADL points (range 0–12).
The Arling groups (with their corresponding relative
nursing usage weights) were as follows:
• Group 1 (1.79 weight): severe functional impairment
(≤9 ADL points) AND (device OR wound)
• Group 2 (1.49 weight): severe functional impairment
(≤9 ADL points) AND absence of device or wound.
• Group 3 (1.25 weight): moderate to severe impairment
(≤7 ADL points) AND completely dependent for feeding
• Group 4 (0.95 weight): moderate to severe impairment
(≤7 ADL points) but NOT completely dependent for
feeding
• Group 5 (0.77 weight): mild to moderate impairment
(5–6 ADL points)
• Group 6 (0.46 weight): mild or no impairment (<5 ADL
points)
Criteria for Groups 1 and 2 were simplified (presence
of any wound, whereas the original criteria specified daily
wound care).16 Thus, a participant was first assigned to a
group based on the modified Arling criteria at baseline and
then assigned the mean relative resource points for that
participant’s group.
Outcome variables were based on the results of
MDRO cultures obtained at baseline and all follow-up vis-
its. Positive colonization for any of the three MDROs
studied (MRSA, R-GNB, VRE) was defined as a positive
culture at any anatomic site (nares, oropharynx, groin,
perianal area) or at any wound or device for that organ-
ism. Prevalent colonization was defined as positive culture
at the baseline visit. A new acquisition was defined as
positive colonization at a follow-up visit and negative at
all sample sites the time before. Thus, time (months) to
new asymptomatic colonization with MRSA, R-GNB, or
VRE could be measured as three separate events.
Statistical Analysis
First, an individual-level cross-sectional observational
analysis of prevalent MDROs (positive MRSA, R-GNB, or
VRE culture found at the baseline as separate outcomes)
was performed using unadjusted logistic regression, using
all candidate variables, including the Arling scale, as uni-
variate predictors.
Next, monthly surveillance samples were used to per-
form a longitudinal survival analysis to assess time
(months) to MDRO acquisition. Rather than the standard
methods of Cox regression, parametric survival analysis,
which requires determination of the functional form of the
hazard of event, was used. A parametric analysis allows
for an estimate of mean time to event, or “life expectancy”
in MDRO-free months, representing when half of the sam-
ple is expected to acquire an MDRO.
A repeated-failure model was also applied, which
allowed time to re-colonization to be estimated in partici-
pants who were colonized transiently.18,19 Application of
this methodology is novel to the infection prevention liter-
ature. The approach captures the dynamic nature of
MDRO transmission (transient vs persistent) in the NH
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setting. In traditional time-to–first event survival analysis,
valuable surveillance data for individuals who are intermit-
tently colonized are discarded after the first occurrence. In
the current study, participants who lost positive MDRO
status across all of their cultured anatomical locations for
2 consecutive months could reenter the analysis and be at
risk for intermittent (recurrent) colonization.
Two additional criteria were used as safeguards to
ensure that a low-level of colonization was not misclassi-
fied as intermittent colonization. First, participants with
MDROs at baseline (who were not eligible for initial
acquisition) could become eligible for recurrent acquisition
after negative cultures were obtained at all anatomical sites
for two consecutive visits. Second, participants were con-
servatively considered to be persistently colonized (ineligi-
ble for recolonization) if an isolated negative culture was
found between two positive cultures or if the last culture
before study exit was an isolated negative culture.
The cumulative baseline hazard monotonically
increased for the acquisition of MDROs over time, allow-
ing for parametric survival analysis. The data best fit a
log–logarithmic distribution using the lowest Akaike infor-
mation criterion, allowing for fitting of an accelerated fail-
ure time survival model:20
Log ðTÞ ¼ a0 þ a1Xþ e;
where T is time in months to MDRO acquisition (MRSA,
R-GNB, VRE), a1 is the acceleration time factor (a multi-
plicative factor of time to event per unit of X), and e is the
error term with the log-logarithmic distribution. Like a
hazard ratio, an acceleration time factor (TF) less than 1
represents a shorter time to event (greater risk). The cumu-
lative baseline hazard of acquiring a recurrent MDRO
(second, third, fourth) was greater than and steeper over
time than for initial MDRO acquisition. Therefore, the
model considered a different baseline hazard according to
initial versus recurrent acquisition.
For all three MDROs, the unadjusted effect of severity
of impairment (six specific ADLs and the Arling scale),
baseline age, sex, presence of indwelling device, and time-
varying predictors (hospitalization, recent antibiotic use,
presence of wound or pressure ulcer within 30 days) on
prevalent MDRO and time to MDRO acquisition was
tested. The Arling scale was focused on as the composite
measure of interest, with multivariable controls for the
presence of antibiotics, hospitalizations, and comorbidity
introduced based on prior evidence.1,8,10
RESULTS
Of the 178 NH participants in the original study, this lon-
gitudinal analysis was conducted on the 111 with two or
more visits (729 visits total). The number of visits (base-
line plus monthly visits) per participant ranged from two
to 13, and the mean number of samples collected was 6
(Table 1). The mean participant age for the analytical
sample was 81; 20% had a wound. The baseline ADL
ability of the participants, along with the nursing resource
usage information, is detailed in Table 1. The flow of data
is shown in Figure 1.
Predictors of Prevalent MDRO Colonization
All participants regardless of baseline colonization status
were included in the initial analysis of prevalent MDRO
colonization. Several characteristics predicted prevalent
MDRO colonization in the NH setting: ADL dependence,
presence of indwelling device, recent wound or pressure
ulcer, recent antibiotic use, and recent hospitalization at
baseline. More specifically and as expected, the 10 partici-
pants with prevalent MRSA colonization were more likely
Table 1. Baseline Characteristics of the Longitudinal
Analysis Sample (n = 111)
Characteristic Value
Age, mean  SD (range) 82  11 (43–103)
Male, n (%) 32 (29)
Number of specimens collected per resident,
mean  SD (range)
6.1  5.9 (2–13)
Residents MDRO positive at baseline (prevalent MDRO), n (%)
MRSA 26 (23)
R-GNB 40 (36)
VRE 11 (10)
Residents acquiring ≥1 new colonizations within 12-month study, n (%)
MRSA 48 (43)
R-GNB 43 (39)
VRE 14 (13)
MDRO acquisitions per resident during the 12-month study,
mean  SD (range)
MRSA 0.54  0.71 (0–3)
R-GNB 0.50  0.71 (0–3)
VRE 0.14  0.37 (0–2)
Residents with ≥1 devices (feeding or
urinary tube) at baseline, n (%)
39 (35)
Residents with wounds or pressure ulcer
(<30 days) at baseline, n (%)
22 (20)
Residents with recent (<30 day) use of
any antibiotic at baseline, n (%)
48 (43)
Residents with a recent hospitalization
(<30 days) at baseline, n (%)
27 (24)
Charlson Comorbidity Index,
mean  SD (range)
2.5  1.5 (0–8)
Activity of daily living impairment at baseline, mean  SD (range)a
Bathing 3.6  0.8 (2–5)
Toileting 3.8  1.3 (1–5)
Feeding 2.7  1.4 (1–5)
Dressing 3.6  1.0 (1–5)
Grooming 3.4  1.0 (1–5)
Ambulation 3.6  0.8 (1–5)
Relative need for nursing care, n (%)b
Group 6 (0.46 weight) 9 (8)
Group 5 (0.77 weight) 17 (15)
Group 4 (0.95 weight) 41 (37)
Group 3 (1.25 weight) 8 (7)
Group 2 (1.49 weight) 0 (0)
Group 1 (1.79 weight) 36 (32)
SD = standard deviation; MDRO = multidrug-resistant organism;
MRSA = methicillin-resistant Staphylococcus aureus; R-GNB = antibiotic-
resistant gram-negative bacteria; VRE = vancomycin-resistant Enterococ-
cus; PSMS = Lawton and Brody Physical Self-Maintenance Scale.
a Defined as in the Lawton and Brody Physical Self-Maintenance Scale
(range 1–5, higher scores indicate more-severe disability).
b Greater weight16 indicates greater need, relative to a “standard” patient
with a weight of 1. The criteria for Groups 1 and 2 were simplified from
the original work by Arling and associates.
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than the 101 who were not colonized at baseline to have a
higher Arling scale score (1.6 vs 1.1, P = .002), an
indwelling device (70% vs 32%, P = .02), a recent hospi-
talization (70% vs 20%, P < .001), or a wound or pres-
sure ulcer (50% vs 17%, P = .01). They also needed more
help with bathing (severity score 4.2 vs 3.5, P = .02), eat-
ing (severity score 3.8 vs 2.6, P = .01), dressing (severity
score 4.3 vs 2.6, P = .03), and grooming (severity score
4.1 vs 3.4, P = .04). Participants with prevalent R-GNB
colonization (n = 26) were more likely than those not
R-GNB
Survival analysis of R-GNB: 
• 71 residents at risk for initial 
acquisition (298 months)
• 41 residents at risk for 
recurrence (163 months)
VRE 
111 residents with ≥2 (baseline + 1 follow-up) observations 
729 total follow-up observations for possible longitudinal analysis
MRSA
Survival analysis of MRSA: 
• 85 residents at risk for initial 
acquisition (429 months)
• 41 residents at risk for 
recurrence (168 months)
Survival analysis of VRE: 
• 100 residents at risk for initial 
acquisition (682 months)
• 11 residents at risk for 
recurrence (56 months) 
101 residents with 60 MRSA 
acquisitions:
• 36 initial 
• 24 recurrent 
85 residents with 56 R-GNB 
acquisitions:
• 34 initial
• 22 recurrent 
106 residents with 15 
VRE acquisitions: 
• 13 initial
• 2 recurrent
178 nursing home residents 
enrolled in longitudinal study
Figure 1. Flow of data from original monthly culture data set to survival analysis datasets. This figure describes the flow of data
from the 178 nursing home residents in the original study to the longitudinal analysis on 111 residents. The analytical data set
for the survival analysis was specific to each organism. Residents who were persistently colonized throughout the entire study
with that organism could not be at risk for acquisition of that organism. Once positive for an organism, a resident with contin-
ued positivity also stopped contributing time at risk. If a resident became negative for at least two consecutive cultures, he or she
could reenter the study and contribute to time at risk for recurrence. MRSA = methicillin-resistant Staphylococcus aureus;
R-GNB = antibiotic-resistant (ceftazidime or ciprofloxacin) gram-negative bacteria; VRE = vancomycin-resistant enterococci.
Table 2. Unadjusted Acceleration Time Factor Survival Models Predicting Months to Initial Multidrug-Resistant
Organism Acquisition
Sample Characteristics and Predictors
Initial Methicillin-Resistant
Staphylococcus aureus
Acquisition
Initial R-GNB
Acquisition
Initial Vancomycin-
Resistant Enterococci
Acquisition
Characteristic
Time at risk, months 429 298 682
Residents, n 85 71 100
New initial acquisition events, n 36 34 13
Predictor, acceleration time factor (95% confidence interval)a
Age (per year) 1.00 (0.97–1.03) 0.97 (0.93–1.00) 0.99 (0.94–1.04)
Male 1.51 (0.69–3.31) 3.18 (1.20–8.39) 0.77 (0.23–2.55)
Arling score (need for nursing care, per point in relative weight) 0.33 (0.17–0.64) 0.52 (0.21–1.27) 0.24 (0.07–0.87)
Impairment in activities of daily living
Feeding 0.81 (0.64–1.02) 0.75 (0.58–0.98)b 0.73 (0.50–1.09)
Bathing 0.80 (0.55–1.15) 0.64 (0.41–1.00) 0.62 (0.30–1.30)
Dressing 0.74 (0.54–1.01) 0.71 (0.50–1.02) 0.58 (0.28–1.23)
Grooming 0.81 (0.61–1.07) 0.77 (0.55–1.10) 0.75 (0.41–1.39)
Walking 0.77 (0.52–1.15) 0.48 (0.30–0.77)b 0.50 (0.23–1.00)
Toileting 0.79 (0.62–1.00) 0.65 (0.50–0.84)b 1.00 (0.67–1.50)
Any device 0.33 (0.18–0.59) 0.96 (0.38–2.41) 0.58 (0.18–1.90)
Any wound or ulcer in 30 days 0.43 (0.17–1.08) 2.18 (0.27–17.86) 0.15 (0.03–0.69)b
Comorbidity 1.01 (0.82–1.25) 0.99 (0.76–1.30) 0.75 (0.52–1.07)
Any hospitalization in 30 days 1.18 (0.22–6.23) 0.43 (0.10–1.87) 0.11 (0.02–0.55)b
Any antibiotics in 30 days 0.85 (0.40–1.83) 0.61 (0.23–1.61) 0.20 (0.05–0.74)b
Example interpretation of acceleration time factor: Time to acquisition of antibiotic-resistant (ceftazidime or ciprofloxacin) gram-negative bacteria
(R-GNB) for a resident with complete dependence in walking (Level 4) is expected to be 48% (roughly twice as fast) of that of a resident with moderate
dependence in walking (Level 3).
a Interpretation of the time factor is similar to a hazard ratio, in that a value <1 is protective, and a value >1 represents greater risk.
b P < .05.
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colonized (n = 85) at baseline to have an indwelling
device (58% vs 28%, P = .006), higher Arling score (1.4
vs 1.1, P = .003), greater need for help with walking
(severity score 4.0 vs 3.5, P = .003), recent antibiotic
use (65% vs 36%, P = .009), a recent hospitalization
(54% vs 15%, P < .001), and a wound or pressure ulcer
(35% vs 15%, P = .03). Similarly, participants with pre-
valent VRE colonization (n = 5) were more likely than
those without (n = 106) to have an indwelling device
(80% vs 30%, P = .03), recent antibiotic use (100% vs
41%, P = .009), and recent hospitalization (100% vs
21%, P < .001). These results demonstrated that individ-
ual risk factors as well as the composite Arling scale
were consistently predictive of prevalent MDRO coloni-
zation.
Time to New and Recurrent MDRO Acquisition
There were 60 instances of MRSA acquisition in partici-
pants, 56 of R-GNB, and 15 of VRE (Figure 1). The med-
ian predicted time to acquisition for MRSA and R-GNB
was less than 1 year (initial MRSA 7.6 months, recurrent
4.6 months, overall (initial or recurrent acquisition) 6.7
months; initial R-GNB 5.1 months, recurrent 4.5 months,
overall 4.9 months). Because there were so few acquisi-
tions of VRE, median predicted time to acquisition
exceeded 12 months (initial 42.0 months, recurrent 13.2
months, overall 39.7 months).
The unadjusted analyses (Table 2) showed that sever-
ity of walking, feeding, and toileting disability was associ-
ated with shorter time to initial R-GNB acquisition.
Walking disability was also associated with shorter time to
initial VRE acquisition. Hospitalization, wounds or pres-
sure ulcers, and antibiotic use in the past 30 days were
also associated with shorter time to initial VRE acquisi-
tion. A hospitalization had occurred within 30 days of
only 3%, 6%, and 23% of the new acquisitions of MRSA,
R-GNB, and VRE, respectively (not shown). On univariate
analysis of time to recurrent acquisition (not displayed),
none of the variables (including Arling score) were signifi-
cant except for age (greater time to MRSA acquisition,
P = .04), comorbidity (less time to R-GNB acquisition,
P = .049), and feeding dependency (less time to VRE
acquisition, P = .02).
As hypothesized, higher nursing resource usage was
correlated with shorter time to MRSA and VRE acquisi-
tion. On multivariable analysis, greater need for overall
nursing according to Arling score was independently asso-
ciated with earlier MRSA and VRE acquisition, indepen-
dent of antibiotic use, hospitalization, or comorbidity.
Predicted time to MDRO acquisition per additional point
on the scale was multiplied by a TF of 0.33 (95%
Figure 2. Greater need for nursing care predicts shorter time to acquisition of methicillin-resistant Staphylococcus aureus
(MRSA) and vancomycin-resistant enterococci (VRE) but not antibiotic-resistant (ceftazidime or ciprofloxacin) gram-negative
bacteria (R-GNB). Graphical display of expected time to multidrug-resistant organism (MDRO) acquisition for MRSA, R-GNB,
and VRE using accelerated failure-time model stratified according to initial versus recurrent acquisition event. The y-axis displays
the predicted number of months to acquisition for initial (solid line) and recurrent (dashed line) MDRO colonization. Residents’
baseline need for nursing resources16 (an ordinal variable assigned with relative weights, where a higher score = more need for
care), expressed as a continuous variable in this analysis, is indicated on the x-axis. Solid circles represent the predictions for
nursing resource usage groups. All predicted times to events are controlled for wounds and pressure ulcers (within 30 days, time
varying), hospitalizations (within 30 days, time varying), antibiotic use (within 30 days, time varying), and comorbidity. For
example, a resident with the least-intense nursing requirement (0.46 relative weight) would be expected to acquire a new MRSA
colonization in 20 months, versus 5 months for residents needing the most-intense nursing (1.8 relative weight).
ARO = antibiotic-resistant organism.
JAGS APRIL 2015–VOL. 63, NO. 4 NURSING INTENSITY AND ANTIMICROBIAL RESISTANCE IN NHS 663
CI = 0.16–0.66) for MRSA acquisition and 0.31 (95%
CI = 0.10–0.95) for VRE acquisition (Figure 2). Predicted
time to initial MRSA acquisition was 20 months for the
lowest need for nursing care and 5 months for the highest,
whereas time to a reacquisition event did not vary accord-
ing to Arling score and was, on average, 5 months (Fig-
ure 2). Time to R-GNB colonization could not be
predicted using the Arling score.
DISCUSSION
This prospective longitudinal study of NH residents under
active surveillance for MDRO acquisition found that the
Arling scale, a simple and validated clinical assessment of
nursing need based on severity of ADL impairment, and
presence of indwelling devices and wounds or pressure
ulcers16 predicted which residents had preexisting MDRO
colonization. It also showed that mean time to new
MDRO acquisition was less than 1 year for MRSA and
R-GNB organisms. After controlling for known risk fac-
tors such as recent hospitalizations and antibiotic use, it
was found that residents with greater nursing need, quanti-
fied using the Arling scale, had shorter time to MRSA and
VRE acquisition.
Colonization by MRSA21,22 or VRE22–24 is associated
with infection by that organism, although less so for R-
GNB.22,25 The results of the current study suggest poten-
tial strategies to prevent MRSA and VRE acquisition in
NHs. From a resident perspective, residents at greater risk,
whenever that risk arises, should be targeted. From a facil-
ity perspective, the results suggest that acquisition occurs
within 6 months of observation, underscoring the urgency
of implementing surveillance and prevention efforts by
identifying high-risk residents early in their NH stay.
A prior study of NH residents showed that limited
mobility and functional disability are associated with
greater prevalence of asymptomatic MRSA.11 Functional
disability has also been associated with high-level gentami-
cin-resistant enterococcal colonization.10 Furthermore, it
has been shown that need for assistance with more than
three ADLs increases the risk of MRSA surgical site infec-
tions in older hospitalized adults.6 Using active surveil-
lance in a cross-sectional study of NH residents, a dose-
response relationship between functional disability and
R-GNB colonization was found.8
Although prior research has identified separate risk
factors, the current study used a parsimonious composite
measure (the Arling scale) that reflects risk factors for
MDROs and assigns greater weight to individuals who
require more nursing contact time. The results suggest that
greater and more-intense contact with healthcare provid-
ers, especially in NH residents with severe ADL impair-
ment and with potential entry points such as indwelling
devices and wounds,16 increases the risk of MDRO coloni-
zation. Residents who are at heightened risk of MDRO
colonization should therefore be targeted for enhanced
barrier precautions.
Although this study was not adequately powered to
determine whether certain individual ADLs predispose to
MDRO acquisition, dressing and toileting, ADL care that
requires skin-to-skin contact with the care provider and
contact with residents’ bacteria-rich skin regions, are
predictors of new MRSA acquisition. In older hospitalized
adults with surgical site infections, it has been shown that
assistance in bathing or dressing increases the risk of
MRSA surgical site infections.6 Although it is probable
that contact-intense ADL dependency reflects underlying
severity of illness, it may be that specific ADL dependency
increases the opportunity for pathogen transmission from
healthcare workers to residents and vice versa.
A higher Arling score did not differentiate time to
acquisition for R-GNB from a lower score. One reason
may be that R-GNB resides specifically in the genitouri-
nary tract and that R-GNB acquisition was therefore asso-
ciated with severe toileting dependency rather than the
Arling scale. Also, combining different organisms and pat-
terns of resistance as a single R-GNB may have resulted in
weaker relationships between risk factors and transmission
than with VRE and MRSA. Future studies should be
designed to identify epidemiologically significant R-GNB
species that are likely to be transmitted to other frail NH
residents or cause infections in this population.
Prior research8,11 considered poor function and
MDRO acquisition in a cross-sectional manner and
reported time to colonization only in colonized residents.
In contrast, this research used survival analysis to predict
each resident’s MDRO-free time at enrollment or the med-
ian expected number of months to acquire MDRO. In
future surveillance research, a delay in time to acquisition
should be considered as an outcome measure of successful
infection prevention.
Several avenues for future research were identified.
Less contribution of recent hospitalization to acquisition
of MRSA and R-GNB (<10% of new cases) was found
than expected, which leads to speculation that the facility
is the source of the MDROs, facilitated by resident charac-
teristics and need for contact-intense nursing, but the role
of healthcare workers’ assistance, environmental contami-
nation, and interaction with resident-level factors that can
lead to new MDRO acquisitions requires further study.
Second, future studies should address whether current
infection prevention interventions such as active surveil-
lance and feedback, as well as use of barrier precautions
when providing help with contact-intense ADLs, leads to
less MDRO transmission in the NH setting. A single-NH
study13 found that preemptive gowning and gloving of all
residents prevents transmission of Klebsiella pneumonia
from resident to resident. A trial of preventive barrier
intervention for residents with indwelling devices is now
under way at 12 NHs.26,27 A third future direction would
be to use Resource Utilization Group scores, which NH,
rather than research, staff routinely collect, as a way to
stratify contact-intense residents who should receive
enhanced MDRO and infection prevention efforts.
One weakness of this study was that new VRE acqui-
sition was uncommon, limiting power to detect an effect
of most of the predictor variables on new VRE acquisition.
Limitations of the current active surveillance methods
include potential false-positive errors due to fluctuating
levels of colonization rather than true recolonization. Sec-
ond, the time that healthcare workers spent providing
assistance with ADLs was not quantified. Third, the data
lacked enough power to include facility-level variables for
any of the MDRO models. Thus, the analysis addressed
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only how resident-level needs contributed to MDRO acqui-
sition. Fourth, the sample size was too small to test for the
effect of individual ADLs on MDRO acquisition. Future
research is needed to examine whether there is facility-level
variation in the link between specific ADLs and new MDRO
acquisition in NH residents, which could lead to more-
targeted preventive interventions. Last, the newer Resource
Utilization Group scores include variables other than the
Arling scale that more accurately predict nursing usage.17,28
More-detailed variables (e.g., specific rehabilitation services
and behavior) that marginally contribute to nursing usage
beyond ADLs (although none more important than ADLs)
could be explored in future studies of MRDO acquisition.
The strength of this study is the use of prospective com-
prehensive monthly collection and microbiological testing of
specimens from NH residents for the presence of MDROs,
which is crucial for detecting new asymptomatic MDRO
colonization. To the knowledge of the authors, this is the
first report of a comprehensive evaluation of nursing
resource usage, as well as the severity of functional disability
and its effect on new MDRO acquisition. The current prac-
tice of identifying resistance in NH residents using passive
surveillance methods represents just the “tip of the iceberg”
of all colonized residents. With sensitive multisite, multivisit
surveillance, it was possible to show the underlying magni-
tude of new MDRO colonization in these residents. Multi-
ple resistance patterns for R-GNB were also tested for,
increasing sensitivity for new MDRO acquisition. Last, a
network of multiple NHs in southeast Michigan with vary-
ing bed size and facility characteristics was used, broadening
the potential generalizability of the results.
In conclusion, contact-intense ADLs that were associ-
ated with shorter time to MDRO colonization were identi-
fied, presenting an opportunity for future interventions to
prevent MDROs in NH residents.
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